跳到正文
原文
Nature 健康护理主题·· 21 天前AI 评分46

重症幸存者流感、肺炎链球菌和SARS-CoV-2疫苗接种率、促进因素和障碍:Mid-German Sepsis Cohort调查

Vaccination rates, facilitators and barriers for influenza, pneumococcal and SARS-CoV-2 vaccination among sepsis survivors: a Mid-German Sepsis Cohort survey

AI 导读

研究在德国对重症幸存者进行了调查,发现流感和肺炎链球菌疫苗接种率在重症后3个月至8年间有所提高,SARS-CoV-2疫苗接种率较高。年龄和教育水平影响流感疫苗接种,全科医生咨询显著提高接种率。研究指出,积极的疫苗咨询和检查可提高接种率,建议作为重症后护理的重要组成部分。

正文

Abstract

Sepsis survivors often suffer from chronic immune dysfunction, leading to frequent rehospitalization and recurrent sepsis. Vaccinations are effective in preventing common infections in sepsis survivors. However, vaccination behavior in this vulnerable population remains unknown. Prospective interviewer-administered survey performed between 04/2023 and 04/2024 among sepsis survivors in Germany. Participants were recruited from the Mid-German Sepsis Cohort (MSC) 6 to 8 years after initial inclusion. We assessed risk perception, cues to action and barriers for vaccination against influenza, pneumococci and SARS-CoV-2. Predictors for the vaccination status of each of the three infections were identified by logistic regression analyses. Among 174 survivors, vaccination rates against influenza and pneumococci rose from 57.3 to 70.7% and from 31.4 to 60.5% 3 months to 8 years post-sepsis, respectively. A total of 135 patients (77.6%) had full vaccination coverage against SARS-CoV-2 at the time of the survey. Higher age and an intermediate vs. low education increased the odds for influenza vaccination. No associations between sociodemographic indicators and the vaccination status against pneumococci and SARS-CoV-2 were found. Vaccination counselling by a general practitioner increased the odds for vaccination between 5.5-fold (influenza) and 3.2-fold (pneumococci) in the multiple regression analyses. The review of general vaccination status was associated with a 4.7-fold increase of influenza vaccination rates and 3.1-fold increase of SARS-CoV-2 vaccination rates. Among patients with at least one missing vaccination (n = 92), impaired mobility (16.8%), long waiting times in the practice (14.8%) and fear of infection in the practice (14.7%) were the most relevant barriers. There are considerable vaccination gaps in sepsis survivors. Pro-active vaccination counselling and checks of vaccination status by general practitioners may offer a great potential to increase vaccination rates and thus should be considered as an important element of sepsis aftercare.

Abbreviations

CCI:

Charlson Comorbidity Index

df:

Degrees of freedom

GP:

General practitioner

ICU:

Intensive care unit

IQR:

Interquartile range

LRT:

Likelihood ratio test

MSC:

Mid-German Sepsis Cohort

OR:

Odds ratio

Q1-Q3:

First quartile to third quartile

SARS-CoV-2:

Severe Acute Respiratory Syndrome Coronavirus 2

SD:

Standard deviation

SOFA:

Sequential organ failure assessment

STIKO:

Standing committee on vaccinations: responsible for vaccination recommendations in Germany, which are necessary for coverage under general health insurance

95% CI:

95% Confidence interval

Acknowledgements

We would like to thank Kristin Töpfer for her support in coordinating the interview appointments and all patients and relatives who agreed to take part in the study.

Funding

Open Access funding enabled and organized by Projekt DEAL. This work was supported by the Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC) at the Jena University Hospital and funded by the German Federal Ministry of Education and Research (BMBF) and by the Rudolf Presl GmbH & Co, Kreischa, Germany. AS and this publication was supported by the BMBF Network of University Medicine 2.0: “NUM 2.0”, Grant No. 01KX2121, Project: Collateral Effects of Pandemics—CollPan.

Author information

Authors and Affiliations

  1. Institute of Infectious Diseases and Infection Control, Jena University Hospital, Stoystraße 3, 07743, Jena, Germany

    Carl Zimmermann, Sebastian Born, Norman Rose, Mathias W. Pletz & Carolin Fleischmann-Struzek

  2. Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany

    Carl Zimmermann, Sebastian Born, Norman Rose, Mathias W. Pletz, André Scherag & Carolin Fleischmann-Struzek

  3. Institute of Medical Statistics, Computer and Data Sciences, Jena University Hospital, Jena, Germany

    André Scherag

  4. Sepsis Foundation, Berlin, Germany

    Konrad Reinhart

Authors

  1. Carl Zimmermann
  2. Sebastian Born
  3. Norman Rose
  4. Mathias W. Pletz
  5. André Scherag
  6. Konrad Reinhart
  7. Carolin Fleischmann-Struzek

Corresponding author

Correspondence to Carolin Fleischmann-Struzek.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

This survey study was approved by the institutional review board of the Friedrich-Schiller-University Jena (2023-2919-Bef).

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zimmermann, C., Born, S., Rose, N. et al. Vaccination rates, facilitators and barriers for influenza, pneumococcal and SARS-CoV-2 vaccination among sepsis survivors: a Mid-German Sepsis Cohort survey. Sci Rep (2026). https://doi.org/10.1038/s41598-026-75831-3

Download citation

  • Received: 28 September 2025

  • Accepted: 09 October 2026

  • Published: 30 October 2026

  • DOI: https://doi.org/10.1038/s41598-026-75831-3

Keywords

来源:Nature 健康护理主题 · nature.com